From: Significance of serum Krebs von den Lungen-6 in systemic sclerosis
Wald | Sig. | OR | 95% C.I. | |||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Age (years) | 0.688 | 3.683 | 0.031* | 1.732 | 1.235 | 4.423 |
Sex | 0.247 | 1.362 | 0.162 | 1.682 | 1.105 | 2.748 |
BMI (wt/(ht)^2) | 0.368 | 3.292 | 0.041* | 2.896 | 1.341 | 7.696 |
Disease duration (years) | 0.408 | 0.765 | 0.961 | 0.459 | 0.122 | 1.137 |
Esophgeal dysmotility | 0.889 | 0.773 | 0.611 | 0.526 | 0.142 | 1.211 |
Raynaud's phenomena | 0.289 | 1.594 | 0.190 | 1.968 | 1.293 | 3.215 |
Digital ulceration | 0.192 | 1.293 | 0.340 | 1.366 | 0.974 | 2.207 |
Digital gangrene | 0.266 | 1.587 | 0.294 | 1.842 | 1.213 | 2.893 |
PAH | 1.040 | 0.904 | 0.715 | 0.615 | 0.166 | 1.417 |
MRSS | 2.531 | 2.028 | 0.049* | 1.848 | 1.452 | 2.945 |
ESR (mm/h) | 0.349 | 0.654 | 0.821 | 0.392 | 0.104 | 0.972 |
CRP | 0.225 | 1.513 | 0.398 | 1.598 | 1.140 | 2.582 |
ANA (IU/ml) | 0.177 | 0.913 | 0.374 | 1.362 | 0.972 | 2.147 |
Anti-SCL70 (IU/ml) | 0.366 | 2.547 | 0.043* | 1.943 | 1.861 | 3.327 |
Krebs von den Lungen-6 (U/ml) | 1.549 | 7.353 | 0.026* | 2.822 | 1.486 | 5.461 |
FVC (L) | 2.254 | 8.349 | < 0.001** | 3.014 | 1.985 | 6.068 |
TLC (L) | 0.994 | 5.736 | 0.027* | 2.712 | 2.056 | 6.446 |
DLCO (L) | 0.889 | 4.710 | 0.029* | 1.740 | 1.646 | 4.915 |
Medsger severity scale | 1.272 | 5.838 | 0.027* | 1.702 | 1.606 | 5.177 |